Author Information
Magnus Ingelman-Sundberg is affiliated with the Department of Physiology and Pharmacology, Section of Pharmacogenetics, Biomedicum 5B, Karolinska Institutet, SE-171 77 Stockholm, Sweden. His research focuses on the fields of pharmacogenetics, pharmacology, and toxicology, with a particular emphasis on the role of cytochrome P450 enzymes in drug metabolism and response.
Research Contributions
Magnus Ingelman-Sundberg has made significant contributions to the understanding of cytochrome P450 enzymes, particularly CYP2C19, CYP2D6, and CYP2E1. His recent studies include the development of a humanized CYP2C19 transgenic mouse model for cerebellar ataxia, the dynamics of metabolic pathways during human neural stem cell differentiation, and the regulation of hepatic CYP2D6 expression. His work also extends into the realm of 3D human liver spheroids, providing valuable tools for translational pharmacology and toxicology, and the prediction of drug pharmacokinetics and hepatotoxicity.
Aliases
Magnus Ingelman-Sundberg is also known by various aliases including:
Magnus Ingelman-sundberg
M. Ingelman-sundberg
M Ingelman-sundberg
M. Ingelman–sundberg
M Ingelman–sundberg
M. Ingelman-sundberg,
Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
41,307 |
| h-index |
104 |
| Total Paper Count |
625 |
